FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and represents a method for making a substratum wherein: a compound exhibiting anticoagulant activity chosen from a group consisting of heparin, thrombomodulin, 4-methoxybenzolsulfonyl-Azp(PEG2000-Ome)-Pro-4-amidinobenzylamido, ATPT and hirudin, and a hydrophilic compound chosen from a group consisting of PVA, PVP, PEG, PPG, a material consisting of polyether and polysiloxane, polyethyleneamine, polyallylamine, polyvinylamine, polyvinylacetate, polyacrylic acid and polyacrylamide, as well as a copolymer or a graft polymer of a monomere of said polymers and another monomere, contacts with substratum which contains an organic solvent in which moisture content makes 25 vol. % or more and 90 vol. % or less, and contains at least secondary or tertiary hydroxyl group; then, the compound exhibiting anticoagulant activity and contacting with the substratum is exposed to irradiation chosen from a group consisting of β-rays, γ-rays, X-rays, electron beam and neutron beam, and unreacted ingredients are washed off by a nonionic surface-active agent.
EFFECT: invention provides reduced washing off the compound exhibiting anticoagulant activity and hydrophilic polymeric compound.
2 cl, 9 ex, 4 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
HYDROPHILIC POLYMER COMPOUND POSSESSING ANTICOAGULATION EFFECT | 2010 |
|
RU2539566C2 |
ANTICOAGULATING BIOLOGICALLY ACTIVE COMPLEX MADE OF SIBERIAN CEDAR BARK | 2007 |
|
RU2366441C2 |
METHOD OF PRODUCTION OF CAPTURE PHYSIOLOGICALLY ACTIVE SUBSTANCES | 2007 |
|
RU2329053C1 |
THROMBIN INHIBITORS, METHOD OF THEIR PRODUCING AND PHARMACEUTICAL COMPOSITION ON SAID | 1994 |
|
RU2138275C1 |
ANTICOAGULATION DRUG | 1996 |
|
RU2146138C1 |
INHIBITORS OF SERINE PROTEASES | 1998 |
|
RU2183642C2 |
ANTICOAGULANT WITH DIRECT ACTION BASED ON MODULAR BIVALENT DNA OF APTAMER SELECTIVE TO THROMBIN | 2016 |
|
RU2631829C1 |
DNA FRAGMENT, RECOMBINANT POLYPEPTIDE EXHIBITING ANTITHROMBIN ACTIVITY, METHOD OF ITS PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION, RECOMBINANT VECTOR (VARIANTS) | 1992 |
|
RU2131462C1 |
HAEMOSTATIC SPONGE | 2011 |
|
RU2562569C2 |
SEPARATION MEMBRANE MODULE | 2017 |
|
RU2747972C2 |
Authors
Dates
2011-03-10—Published
2007-09-13—Filed